Inhibition of serum and transforming growth factor beta (TGF-β1)-induced DNA synthesis in confluent airway smooth muscle by heparin

British Journal of Pharmacology

Volumn 125, Issue 4, 1998, Pages 599-606

  Okona Mensah, K B ^a   Shittu, E ^b   Page, C ^a   Costello, J ^a   Kilfeather, S A ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

Airway; DNA synthesis; Epidermal growth factor; Glycosaminoglycans; Heparin; Mitogenesis; Smooth muscle; Tissue remodelling; Transforming growth factor beta

Indexed keywords

ANTICOAGULANT AGENT; BOVINE SERUM ALBUMIN; EPIDERMAL GROWTH FACTOR; HEPARIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATTLE; CELL CYCLE S PHASE; CELL DIVISION; DNA SYNTHESIS; DNA SYNTHESIS INHIBITION; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; TRACHEA MUSCLE;

ANIMALS; ASTHMA; BLOOD PHYSIOLOGY; CATTLE; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; HEPARIN; MUSCLE, SMOOTH; NUCLEIC ACID SYNTHESIS INHIBITORS; TRACHEA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031787235     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702046     Document Type: Article

References (46)

1. ASSOIAN, R.K., KOMORIYA, A., MEYWERS, C.A., MILLER, D.M. & SPORN, M.B. (1983). Transforming growth factor-beta in human platelets: identification of a major storage site, purification and characterisation. J. Biol. Chem., 258, 7155-7160.
2. ASSOIAN, R.K. & SPORN, M.B. (1986). Type β transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J. Cell. Biol., 102, 1217-1223.
3. AUBERT, J.D., DALAL, B.I., BAI, T.R., ROBERTS, C.R., HAYASHI, S. & HOGG, J.C. (1994). Transforming growth factor β1 gene expression in human airways. Thorax, 49, 225-232.
4. BASSING, C.H., YINGLING, J.M. & WANG, X.F. (1994). Receptors for the TGF-beta ligand family. Vitam. Horm., 48, 111-156.
5. BLACK, P.N., YOUNG, P.G. & SKINNER, S.J.M. (1996). Response of airway smooth muscle cells to TGF-beta 1: Effects on growth and synthesis of glycosaminoglycans. Am. J. Physiol., 15, L910-L917.
6. BORDER, W.A. & RUOSLAHTI, E. (1992). Transforming growth factor-beta in disease: the dark side of tissue repair. J. Clin. Invest., 90, 1-7.
7. CAMPBELL, J.H., RENNICK, R.E., KALEVITCH, S.G. & CAMPBELL, G.R. (1992). Heparan sulphate degrading enzymes induce modulation of smooth muscle phenotype. Exp. Cell Res., 200, 156-167.
8. COHEN, D., CIOCCA, V. & PANETTIERI, R.A. (1997). TGF-β1 modulates human airway smooth-muscle cell proliferation induced by mitogens. Am. J. Resp. Cell Mol. Biol., 16, 85-90.
9. 2 by bovine cultured airway smooth muscle cells and its inhibition by cyclo-oxygenase inhibitors. Br. J. Pharmacol., 111, 983-9888.
10. DUNNIL, M.S. (1969). The pathophysiology of asthma, with special interest to changes in the bronchial mucosa. J. Clin. Path., 13, 27-33.
11. EBINA, M., CHIBA, R., YAEGASHI, H., MITOMIYA, M. & TAKEMURA, M. (1990). Hyperactive site in the airway tract of asthmatics patients revealed by thickening of bronchial muscles: a morphological study. Am. Rev. Respir. Dis., 141, 1327-1332.
12. EBINA, M., TAKAHASHI, T., CHIBA, R. & MITOMIYA, M. (1993). Cellular hypertrophy and hyperplasia of airway smooth muscle underlying bronchial asthma. Am. Rev. Respir. Dis., 148, 720-726.
13. ELOVIC, A., WONG, D.T., WELLER, P.F., MATOSSIAN, K. & GALLI, S.J. (1994). Expression of transforming growth factors-alpha and beta 1 messenger RNA and product by eosinophils in nasal polyps. J. Allergy Clin. Immunol., 93, 864-869.
14. FUKUDA, N. (1993). Suppression of the exaggerated growth of vascular smooth muscle cells from SHR by antisense oligodeoxynucleotide to TGF beta. Nippon-Rinsho., 51, 1663-1667.
15. GIBBON, G.H. & DZAU, V.J. (1994). The emerging concept of vascular remodelling. New Eng. J. Med., 330, 1431-1438.
16. GIRI, S.N., HYDE, D.M. & HOLLINGER, M.A. (1993). Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax, 48, 959-966.
17. GOODMAN, L.V. & MAJACK, R.A. (1989). Vascular smooth muscle cells express distinct transforming growth factor beta receptor phenotypes as a function of cell density in culture. J. Biol. Chem., 264, 4241-4244.
18. GOSPODAROWICZ, D., GREENE, G. & MORAN, J. (1975). Fibroblast growth factor can substitute for platelet factor to sustain the growth of Balb/3T3 cells in the presence of plasma. Biochem. Biophys. Res. Commun., 65, 779-787.
19. HALAYKO, A.J., DELACRUZ, R. & STEPHENS, N.L. (1994). Heparin sulphate inhibits proliferation of cultured airway smooth muscle cells, but does not prevent phenotypic modulation. Amer. J. Respir. Crit. Care Med., 149(4), A300.
20. HAMET, P., HADRAVA, V., KRUPPA, U. & TREMBLAY, J. (1991). Transforming growth factor beta 1 expression and effect in aortic smooth muscle cells from spontaneously hypertensive rats. Hypertension, 17, 896-901.
21. HIRST, S.J., BARNES, P.J. & TWORT, C.H.C. (1992). Quantifying proliferation of cultured human and rabbit airway smooth muscle cells in response to serum and platelet-derived growth factor. Am. J. Respir. Cell Mol. Biol., 7, 574-581.
22. JAMES, A.L., HOGG, J.C. & PARE, P.D. (1989). The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis., 139, 242-246.
23. 2 inhibit DNA synthesis in human airway smooth muscle cells in culture. Am. J. Physiol., 269, L514-L519.
24. KARNOVSKY, M.J. & EDELMAN, E.R. (1994). Heparin/heparan sulphate regulation of vascular smooth muscle behaviour. In Airways and vascular remodelling in asthma and cardiovascular disease-implications for therapeutic intervention. eds. Black, J., Page, C.P. pp. 45-55. New York, Academic Press.
25. KILFEATHER, S.A., TAGOE, S., PEREZ, A.C., OKONA-MENSAH, K., MATIN, R. & PAGE, C.P. (1995a). Inhibition of serum-induced proliferation of bovine tracheal smooth muscle cells in culture by heparin and related glycosaminoglycans. Br. J. Pharmacol., 114, 1442-1446.
26. KILFEATHER, S.A., OKONA-MENSAH, K.B., TAGOE, S., COSTELLO, J. & PAGE, C. (1995b). Stimulation of airway smooth muscle cell mitogenesis by transforming growth factor beta (TGF-β1) and inhibition by heparin and explant-conditioned media. Eur. Respir. J., 8, 547s.
27. KILFEATHER, S.A., OKONA-MENSAH, K.B., SHITTU, E., TAGOE, S., COSTELLO, J. & PAGE, C. (1996). Airway smooth muscle-conditioned media contains both mitogenic and antimitogenic factors. Am. J. Respir. Crit. Care Med., 153, A843.
28. LAURENT, G.J., COKER, R.K. & MCNAULTY, R.J. (1993). TGF-β antibodies: a novel treatment for pulmonary fibrosis? Thorax. 48, 953-954.
29. LINDAHL, U., LIDHOLT, K., SPILLMANN, D. & KJELLEN, L. (1994). More to 'heparin' than anticoagulation. Thromb. Res., 75, 1-32.
30. MAJACK, R.A., MAJESKY, M.W. & GOODMAN, L.V. (1990). Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-beta. J. Cell. Biol., 111, 239-247.
31. MIYAZONO, K., TEN-DIJKE, P., ICHIJO, H. & HELDIN, C.H. (1994). Receptors for transforming growth factor-beta. Adv. Immunol., 55, 181-220.
32. NUGENT, M.A. & EDELMAN, E.R. (1992). Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: a mechanism for cooperativity. Biochemistry, 31, 8876-8883.
33. OHNO, I., LEA, R.G., FLANDERS, K.C., CLARK, D.A., BANWATT, D., DOLOVICH, J., DENBURG, J., HARLEY, C.B., GAULDIE, J. & JORDANA, M. (1992). Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J. Clin. Invest., 89, 1662-1668.
34. PARIS, S., MAGNALDO, I. & POUYSSEGUR, J. (1988). Homologous desensitization of thrombin-induced phosphoinositide breakdown in hamster lung fibroblasts. J. Biol. Chem., 263, 11250-11256.
35. RANGANATHAN, G. & GETZ, M.J. (1990). Cooperative stimulation of specific gene transcription by epidermal growth factor and transforming growth factor type beta 1. J. Biol. Chem., 265, 3001-3004.
36. ROSS, J., JANERO, D.R. & HRENIUK, D. (1993a). Identification and biochemical characterization of a heart-muscle cells transforming growth factor beta-1 receptor. Biochem. Pharmacol., 46, 511-516.
37. ROSS, J., JANERO, D.R. & HRENIUK, D. (1993b). Identification and molecular characterization of a high-affinity cardiomyocyte transforming growth factor-beta 2 receptor. FEBS-Lett., 320, 229-234.
38. SAN ANTONIO, J.D., LANDER, A.D., WRIGHT, T.C. & KARNOVSKY, M.J. (1992). Heparin inhibits the attachment and growth of Balb c-3T3 fibroblasts on collagen substrata. J. Cell Physiol., 150, 8-16.
39. SKALLI, O., ROPRAZ, P., TRZECIAK, A., BENZONANA, G., GILLESSEN, D. & GABBIANI, G. (1986). A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J. Cell Biol., 103, 2787-2796.
40. SPORN, M.B. & ROBERTS, A.B. (1990). The transforming growth factor-beta. In Peptide Growth Factors and Their Receptors I. eds Sporn, M.B. and Roberts, A.B. p. 419. New York: Springer-Verlag.
41. STEWART, A.G., GRIGORIADIS, G. & HARRIS, T. (1994). Mitogenic actions of endothelin-1 and epidermal growth factor in cultured airway smooth muscle. Clin. Exp. Pharmacol. Physiol., 21, 277-285.
42. TAYLOR, I.K., SOROOSHIAN, M., WANGOO, A., HAYNES, A.R., KOTECHA, S., MITCHELL, D.M. & SHAW, R.J. (1994). Platelet-derived growth factor-beta mRNA in human alveolar macrophages in vivo in asthma. Eur. Respir. J., 7, 1966-1972.
43. THYBERG, T., HEDIN, U., SJOLUND, M., PALMBERG, L. & BOTTGER, B.A. (1990). Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Atherosclerosis 10, 966-990.
44. TOMLINSON, P.R.T., WILSON, J.W. & STEWART, A.G. (1994). Inhibition by salbutamol of the proliferation of human airway smooth muscle cells grown in culture. Br. J. Pharmacol., 111, 641-647.
45. TOMLINSON, P.R.T., WILSON, J.W. & STEWART, A.G. (1995). Salbutamol inhibits the proliferation of human airway smooth muscle cells grown in culture: relationship to elevated cAMP levels. Biochem. Pharmacol., 49, 1809-1819.
46. WRIGHT, T.C., PUKAC, L.A., CASTELLOT, J.J., KARNOVSKY, M.J., LEVINE, R.A., KIM-PARK, G.H. & CAMPISI, J. (1989). Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc. Natl. Acad. Sci. U.S.A., 86, 3199-3203.